FIELD: medicine.
SUBSTANCE: pharmaceutical composition, being solid drug, comprises nucleus containing Tamoxiphene, Di-indolyl methane as active substances, binding substance, at least one antioxidant, loosener, filler, stabilizer selected from a group containing polyvinyl pyrrolidon, croscarmelose, sodium alginate, calcium glycerophosphate or their mixtures and intestine-soluble coating.
EFFECT: enhanced effectiveness of treatment; reduced risk of adverse side effects.
4 cl, 4 dwg
